Ligand validation:6FZB

SRY: STREPTOMYCIN

SRY is a Ligand Of Interest in 6FZB designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6FZB_SRY_B_301	39%	31%	0.157	0.861	1.4	1.34	2	5	0	0	100%	1
6FZB_SRY_A_301	18%	30%	0.208	0.793	1.39	1.39	2	5	0	0	100%	1
5LUH_SRY_A_304	70%	43%	0.092	0.908	0.68	1.49	2	6	0	0	100%	0.9865
4DR7_SRY_A_1928	68%	7%	0.153	0.964	2.36	2.54	11	16	0	0	100%	1
4JI1_SRY_A_1601	65%	11%	0.17	0.972	2.3	1.95	11	13	1	1	100%	1
4DR5_SRY_A_1860	64%	9%	0.165	0.965	2.41	2.03	10	10	6	0	100%	1
4DR6_SRY_A_1956	58%	8%	0.196	0.975	2.44	2.19	10	11	7	0	100%	1
4DV3_SRY_A_1601	57%	7%	0.185	0.96	2.37	2.39	11	15	6	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.